Explore the sections below for an overview of some of the innovative heart and vascular techniques and technologies that have been developed at Brigham and Women’s Hospital, videos of innovative procedures, stories about patients who have benefitted from heart and vascular advances, and details about ongoing research.
Today there are more recipients waiting for organ transplants than there are organs available. And while the current opioid crisis has produced more available organs for transplantation, those with hepatitis C viral infection have previously been considered ineligible. With a new antiviral treatment regimen, could it be possible to transplant these organs, prevent the establishment of hepatitis C in the recipients, and produce an excellent outcome in patients? A team of infectious disease experts, transplant physicians and surgeons from the Brigham proved, with an effectiveness of 100 percent, that it is.